Targeted therapy is used to treat Chronic Myeloid Leukemia (CML), not Chronic Myelomonocytic Leukemia (CMML). Here are some key points about targeted therapy for CML:

- Targeted Therapy Drugs: These drugs recognize and attack molecules specifically found on cancer cells
- Philadelphia Chromosome: Most people with CML have Show Full Answer

Targeted therapy is used to treat Chronic Myeloid Leukemia (CML), not Chronic Myelomonocytic Leukemia (CMML). Here are some key points about targeted therapy for CML:

- Targeted Therapy Drugs: These drugs recognize and attack molecules specifically found on cancer cells.
- Philadelphia Chromosome: Most people with CML have a gene change called the Philadelphia chromosome, which creates an abnormal protein called BCR-ABL.
- Tyrosine Kinase Inhibitors (TKIs): These are the primary targeted therapy drugs for CML. Examples include:
- Imatinib (Gleevec)
- Dasatinib (Sprycel)
- Bosutinib (Bosulif)
- Nilotinib (Tasigna)
- Ponatinib (Iclusig) for specific mutations

TKIs are often the first line of treatment and can be very effective in managing CML.

 This AI-generated response comes from MyLeukemiaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

The Benefits of Targeted Therapy for Leukemia | MyLeukemiaTeam

Chronic Myeloid Leukemia Treatment Options | MyLeukemiaTeam